|
This is an index of adverse event reports related to Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (20)
Cases resulting in a serious event (18)
Cases resulting in life threatening events (1)
Cases resulting in hospitalization (9)
Cases resulting in disability (2)
Cases resulting in other serious reactions (11)
Adverse event in female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Wrong Drug Administered, Suppressed Lactation, Depression, Toothache, Drug Dispensing Error, Menorrhagia, Accidental Exposure
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Adverse event in 23 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a individual with unspecified qualification from United States on 2007-10-05
Patient: 23 year old female, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Pruritus, Oedema Peripheral
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Adverse event in female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a consumer/non-health professional from United States on 2007-07-20
Patient: female, weighing 59.9 kg (131.7 pounds)
Adverse reactions / side effects: Asthma
Suspect drug(s):
Ortho TRI-Cyclen
Administration route: Oral
Indication: Menstruation Irregular
Ortho TRI-Cyclen
Administration route: Oral
Indication: Contraception
Adverse event in 37 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-13
Patient: 37 year old female, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Cerebellar Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Ortho Evra
Dosage: transdermal
Indication: Contraception
Start date: 2005-06-01
Ortho TRI-Cyclen
Indication: Contraception
Other drugs received by patient: Neurontin; Allegra; Amitriptyline HCL; Ambien
Adverse event in 22 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a physician from United States on 2007-07-13
Patient: 22 year old female, weighing 146.4 kg (322.1 pounds)
Adverse reactions / side effects: Pulmonary Embolism
Adverse event resulted in: hospitalization
Suspect drug(s):
Ortho Evra
Dosage: transdermal
Indication: Contraception
Ortho TRI-Cyclen
Dosage: 1 dose (s), 1 in 1 day
Indication: Drug USE FOR Unknown Indication
Start date: 2004-01-01
End date: 2006-09-01
Other drugs received by patient: Glucophage (Jnj16269110 Comparator) Tablet; Actos (Pioglitazone) Unspecified; Advair (Seretide Mite) Unspecified
Adverse event in 22 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-13
Patient: 22 year old female, weighing 67.1 kg (147.7 pounds)
Adverse reactions / side effects: Acute Myocardial Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Ortho Evra
Dosage: 1 dose(s), 3 in 4 week, transdermal
Indication: Contraception
Start date: 2003-01-01
End date: 2003-03-01
Ortho Evra
Dosage: 1 dose(s), 3 in 4 week, transdermal
Indication: Contraception
Start date: 2003-05-01
Ortho TRI-Cyclen
Indication: Contraception
Start date: 2002-07-10
Other drugs received by patient: Singular (Montelukast Sodium)
Adverse event in 21 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-13
Patient: 21 year old female, weighing 80.7 kg (177.6 pounds)
Adverse reactions / side effects: Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Ortho Evra
Dosage: transdermal
Indication: Contraception
Start date: 2003-03-19
End date: 2005-08-16
Ortho TRI-Cyclen
Dosage: 1 in 1 day, oral
Administration route: Oral
Indication: Contraception
Start date: 2005-08-16
End date: 2006-04-29
Other drugs received by patient: Motrin; Naprosyn; Acetaminophen
Adverse event in 20 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a physician from United States on 2007-06-27
Patient: 20 year old female
Adverse reactions / side effects: Drug Interaction, Convulsion
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Other drugs received by patient possibly interacting with the suspect drug:
Trileptal
Indication: Convulsion
Adverse event in female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-27
Patient: female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Withdrawal Bleeding Irregular, Withdrawal Bleed
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Adverse event in 18 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a physician from United States on 2007-06-27
Patient: 18 year old female
Adverse reactions / side effects: Weight Increased, Dysphonia, Dehydroepiandrosterone Increased, Abnormal Behaviour
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Adverse event in 27 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a consumer/non-health professional from United States on 2007-06-15
Patient: 27 year old female, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Pain, Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Ortho TRI-Cyclen
Dosage: 21 day regimen 1 x day po
Administration route: Oral
Indication: Contraception
Start date: 2000-01-01
End date: 2007-04-01
Ortho TRI-Cyclen LO
Dosage: 21 day regimen 1 x day po
Administration route: Oral
Indication: Contraception
Start date: 2000-01-01
End date: 2007-04-01
YAZ
Dosage: 24 day regimen 1 x day po
Administration route: Oral
Indication: Contraception
Start date: 2007-04-01
End date: 2007-05-01
YAZ Bayer Healthcare
Dosage: 24 day regimen 1 x day po
Administration route: Oral
Indication: Contraception
Start date: 2007-04-01
End date: 2007-05-01
Other drugs received by patient: Prozac; Prozac
Adverse event in 20 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a physician from United States on 2007-05-04
Patient: 20 year old female
Adverse reactions / side effects: Drug Interaction, Convulsion
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Other drugs received by patient possibly interacting with the suspect drug:
Trileptal
Indication: Convulsion
Adverse event in 40 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a individual with unspecified qualification from United States on 2007-03-26
Patient: 40 year old female, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Headache, Metrorrhagia
Suspect drug(s):
Ortho TRI-Cyclen
Indication: Contraception
Ortho TRI-Cyclen LO
Indication: Contraception
Adverse event in female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a physician from United States on 2007-03-06
Patient: female, weighing 146.4 kg (322.1 pounds)
Adverse reactions / side effects: Pulmonary Embolism
Adverse event resulted in: hospitalization
Suspect drug(s):
Ortho Evra
Indication: Contraception
Ortho TRI-Cyclen
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Glucophage; Actos; Advair Diskus 100 / 50
Adverse event in 17 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a pharmacist from United States on 2007-02-27
Patient: 17 year old female, weighing 62.6 kg (137.7 pounds)
Adverse reactions / side effects: Dehydration, Sinus Headache, Superior Sagittal Sinus Thrombosis, Lethargy
Adverse event resulted in: hospitalization
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Adverse event in 23 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a physician from United States on 2007-02-21
Patient: 23 year old female, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Cerebral Infarction
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Adverse event in 26 year old female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a consumer/non-health professional from United States on 2007-02-01
Patient: 26 year old female, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Hot Flush, Amenorrhoea, Acne, Alopecia, Intra-Uterine Contraceptive Device Expelled, Vaginal Infection, Ectopic Pregnancy
Suspect drug(s):
Mirena
Dosage: 20 ug/day, cont, intra-uterine
Indication: Contraception
Start date: 2002-08-01
Ortho TRI-Cyclen
Dosage: 1 tab(s), 1x/day, oral
Administration route: Oral
Other drugs received by patient: Lexapro
Adverse event in male receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a physician from United States on 2007-02-01
Patient: male, weighing 3.2 kg (7.0 pounds)
Adverse reactions / side effects: Neonatal Aspiration, Bradycardia Neonatal
Adverse event resulted in: hospitalization
Suspect drug(s):
Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Adverse event in female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a consumer/non-health professional from United States on 2007-01-23
Patient: female, weighing 64.9 kg (142.7 pounds)
Adverse reactions / side effects: Colitis Ulcerative
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Ortho TRI-Cyclen
Indication: Acne
Ortho TRI-Cyclen
Indication: Drug Therapy
Ortho TRI-Cyclen
Indication: Acne
Ortho TRI-Cyclen
Indication: Drug Therapy
Adverse event in female receiving Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-19
Patient: female, weighing 70.3 kg (154.7 pounds)
Adverse reactions / side effects: Hypotrichosis, Alopecia
Suspect drug(s):
Ortho Evra
Dosage: 1 patch per week transderma
Indication: Contraception
Start date: 2005-06-02
End date: 2005-09-01
Ortho TRI-Cyclen
Dosage: 1 pill per day po
Administration route: Oral
Indication: Contraception
Start date: 2006-09-01
End date: 2006-09-30
|
